Literature DB >> 16871252

Myostatin and insulin-like growth factors in uremic sarcopenia: the yin and yang in muscle mass regulation.

R H Mak1, P Rotwein.   

Abstract

Myostatin and the insulin-like growth factors (IGF-I and -II) play inhibitory and stimulatory roles, respectively, in the development and regulation of skeletal muscle mass. The findings of Sun et al. in this issue shed light on the potential regulation and actions of this yin-and-yang system in uremic sarcopenia and the salutary effects of exercise.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16871252     DOI: 10.1038/sj.ki.5001622

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

1.  A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice.

Authors:  Wai W Cheung; Wei Ding; Sujana S Gunta; Yong Gu; Rinat Tabakman; Leah N Klapper; Arieh Gertler; Robert H Mak
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

Review 2.  Inflammation and cachexia in chronic kidney disease.

Authors:  Wai W Cheung; Kyung Hoon Paik; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-01-29       Impact factor: 3.714

3.  Interdialytic creatinine change versus predialysis creatinine as indicators of nutritional status in maintenance hemodialysis.

Authors:  Carl P Walther; Caitlin Wise Carter; Chai L Low; Peter Williams; Dena E Rifkin; Robert W Steiner; Joachim H Ix
Journal:  Nephrol Dial Transplant       Date:  2011-07-20       Impact factor: 5.992

Review 4.  The growth hormone-insulin-like growth factor-I axis in chronic kidney disease.

Authors:  Robert H Mak; Wai W Cheung; Charles T Roberts
Journal:  Growth Horm IGF Res       Date:  2007-09-07       Impact factor: 2.372

5.  Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.

Authors:  Wai W Cheung; Robert H Mak
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-22

6.  Identifying growth hormone-regulated enhancers in the Igf1 locus.

Authors:  Damir Alzhanov; Aditi Mukherjee; Peter Rotwein
Journal:  Physiol Genomics       Date:  2015-09-01       Impact factor: 3.107

Review 7.  Target population for clinical trials on sarcopenia.

Authors:  M Cesari; M Pahor
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

Review 8.  Regulation of muscle protein synthesis and the effects of catabolic states.

Authors:  Bradley S Gordon; Andrew R Kelleher; Scot R Kimball
Journal:  Int J Biochem Cell Biol       Date:  2013-06-12       Impact factor: 5.085

Review 9.  Non-crystalline and crystalline rheumatic disorders in chronic kidney disease.

Authors:  Pasha Sarraf; Jonathan Kay; Anthony M Reginato
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

10.  The salmonid myostatin gene family: a novel model for investigating mechanisms that influence duplicate gene fate.

Authors:  Casey B Lawson; Takumu Niino; Russell A Hermansen; Vera Brok-Volchanskaya; Melissa F Jackson; Dilip K Garikipati; David A Liberles; Buel D Rodgers
Journal:  BMC Evol Biol       Date:  2012-10-08       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.